139 related articles for article (PubMed ID: 8712840)
21. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus infection: a possible promoting agent in porphyria cutanea tarda.
Antonov K; Krastev Z; Teoharov P; Zaharieva E; Alexiev A; Ivanova A; Adjarov D
Ital J Gastroenterol; 1996 Dec; 28(9):482-6. PubMed ID: 9131391
[TBL] [Abstract][Full Text] [Related]
23. [Porphyria cutanea tarda and hepatitis C virus infection].
Held E; Petersen CS
Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
[TBL] [Abstract][Full Text] [Related]
24. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
25. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
[TBL] [Abstract][Full Text] [Related]
26. Type of impaired porphyrin metabolism caused by hepatitis C virus is not porphyria cutanea tarda but chronic hepatic porphyria.
Gomi H; Hatanaka K; Miura T; Matsuo I
Arch Dermatol; 1997 Sep; 133(9):1170-1. PubMed ID: 9301601
[No Abstract] [Full Text] [Related]
27. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
Tarwater K; Misra S; Misra M
Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769
[TBL] [Abstract][Full Text] [Related]
28. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
29. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
[TBL] [Abstract][Full Text] [Related]
30. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
31. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study.
Dai CY; Chuang WL; Ho CK; Hsieh MY; Huang JF; Lee LP; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
J Hepatol; 2008 Jul; 49(1):9-16. PubMed ID: 18486265
[TBL] [Abstract][Full Text] [Related]
32. Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus.
Mauboussin JM; Mahamat A; Peyrière H; Rouanet I; Fabbro-Peray P; Daures JP; Vincent D
HIV Med; 2004 May; 5(3):151-7. PubMed ID: 15139980
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
Dezzutti CS; Astemborski J; Thomas DL; Marshall JH; Cabrera T; Purdy M; Vlahov D; Garfein RS
J Clin Virol; 2004 Nov; 31(3):210-4. PubMed ID: 15465414
[TBL] [Abstract][Full Text] [Related]
34. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
35. Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people.
Polgreen PM; Fultz SL; Justice AC; Wagner JH; Diekema DJ; Rabeneck L; Weissman S; Stapleton JT
HIV Med; 2004 May; 5(3):144-50. PubMed ID: 15139979
[TBL] [Abstract][Full Text] [Related]
36. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
37. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.
O'Connor WJ; Badley AD; Dicken CH; Murphy GM
Mayo Clin Proc; 1998 Sep; 73(9):895-7. PubMed ID: 9737229
[TBL] [Abstract][Full Text] [Related]
38. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
39. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection].
Rao HP; Feng L; Li D; Bader A; Wu NP
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210
[TBL] [Abstract][Full Text] [Related]
40. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
